LX2761

Catalog No. A20597

LX2761 is chemically stable and potent inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 in vitro with IC50s of 2.2 nM and 2.7nM for hSGLT1 and hSGLT2, but displays specific SGLT1 inhibition in the gastrointestinal (GI) tract.
Catalog Num A20597
M. Wt 601.8
Formula C32H47N3O6S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1610954-97-6
Synonyms LX-2761, LX2761
SMILES CC1=CC=C([C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](SC)O2)C=C1CC3=CC=C(CCCC(NC(C(NCCN(C)C)=O)(C)C)=O)C=C3
LX2761 is chemically stable and potent inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 in vitro with IC50s of 2.2 nM and 2.7nM for hSGLT1 and hSGLT2, but displays specific SGLT1 inhibition in the gastrointestinal (GI) tract.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 16.62 mL 83.08 mL 166.17 mL
0.5 mM 3.32 mL 16.62 mL 33.23 mL
1 mM 1.66 mL 8.31 mL 16.62 mL
5 mM 0.33 mL 1.66 mL 3.32 mL

*The above data is based on the productmolecular weight 601.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.